Unit 8 Medications for Sleep Disorders. 800w. 4 references. Due 10-22-23

1. What screening tools can be used to affirm your initial diagnosis that a patient may meet the diagnostic criteria for a sleep disorder?

2. Describe the pharmacological actions of non-z sleep medications?

3. What problems can occur when benzodiazepines are used to help with sleep?

Responses need to address all components of the question, demonstrate critical thinking and analysis and include peer-reviewed journal evidence to support the student’s position.

Please be sure to validate your opinions and ideas with in-text citations and corresponding references in APA format.

Please review the rubric to ensure that your response meets the criteria.

https://www.apa.org/monitor/2022/07/ce-sleep-disorders

CONTINUING EDUCATION

Diagnosing and treating sleep disorders

Psychologists have a leading role to play in treating insomnia and other common sleep disturbances

By 

Kirsten Weir
Date created: July 1, 202214 min read

Vol. 53 No. 5
Print version: page 40

·
Sleep

9

CE credits: 1

Learning objectives: After reading this article, CE candidates will be able to:

1. Describe symptoms of common sleep disorders.

2. Understand and access tools available for screening clients for sleep disorders.

3. Describe evidence-based behavioral treatments for insomnia and other sleep disorders.

4. Know when to refer clients to sleep specialists.

For more information on earning CE credit for this article, go to 

CE Corner
.

Psychologists have a leading role to play in treating insomnia and other common sleep disturbances.

Sleep is a biological necessity. But for all its importance, it can be surprisingly hard to get enough. As many as 50 to 70 million U.S. adults have a sleep disorder, according to the American Sleep Association. Those disorders frequently go hand in hand with problems such as depression, anxiety, and posttraumatic stress disorder (PTSD). “Sleep disorders are very common and are often comorbid with mental health conditions. But psychologists get very little training in sleep,” said Jennifer Mundt, PhD, director of the Northwestern University Behavioral Sleep Medicine Training Program, who presented the continuing-education session “Sleep and Its Disorders: A Primer for Mental Health Professionals” for APA in 2021.

In a recent survey of clinical psychologists in the United States and Canada, practitioners reported a median of just 10 hours of sleep training across their education and career, and 95% reported no clinical sleep training during graduate school, internship, or fellowship (Zhou, E. S., et al., 


Behavioral Sleep Medicine

, Vol. 19, No. 6, 2021
). “In medicine, psychology, and society as a whole, we’ve paid so little attention to sleep for so long,” Mundt said.

It is time to start paying attention, Mundt and other sleep experts say. “Sleep is critical to physical and emotional health, and when it’s disrupted, it cuts across both,” said Susan Rubman, PhD, a behavioral sleep medicine specialist and assistant professor of psychiatry at the Yale School of Medicine. “As a basic part of psychological assessment, it’s important to know what normal sleep is and what disordered sleep is so you can treat all aspects of an individual’s concerns appropriately.”

ADVERTISEMENT

Sleep facts and fictions

Sleep disorders come in all shapes and sizes. The most common is insomnia, which is characterized by difficulty falling or staying asleep. About 30% of adults in the United States have symptoms of insomnia, and about 10% have insomnia that is severe enough to cause daytime consequences, according to the American Academy of Sleep Medicine (AASM). And insomnia comes with a host of complications, including increased risk of accidents, poor performance at work or school, and elevated risk of conditions including high blood pressure, heart disease, depression, and substance use disorders. It is also associated with an increased risk of suicide as well as death from other causes.

Insomnia and other sleep disorders often coexist with other psychological complaints. Up to 90% of people with depression have sleep complaints, and two thirds of people undergoing a major depressive episode experience insomnia, according to a review by University of Pittsburgh researchers Peter Franzen, PhD, and Daniel Buysse, MD. Sleep disturbances often precede depressive symptoms, they found, and are associated with worse clinical and treatment outcomes among people with depression (


Dialogues in Clinical Neuroscience

, Vol. 10, No. 4, 2008
).

All that is to say that clinical psychologists are certain to treat patients who have trouble sleeping whether they know it or not. And there are three good reasons to address sleep in practice, said Michael Grandner, PhD, MTR, director of the Sleep and Health Research Program at the University of Arizona. “First, we know that sleep affects health and functioning. Second, sleep is often a way into mental health issues. Asking how someone is sleeping is a great way to start talking about mental health,” he said. “And the third reason is that sleep problems are highly fixable, without medications. And psychologists are in a prime position to fix them.”

Yet there are some common misconceptions about sleep—among the public as well as health care professionals—that prevent people from getting the treatment they need for insomnia and other sleep disorders. One is the belief that good sleep hygiene can cure disordered sleep, Grandner said. Sleep hygiene includes practices like going to bed and waking up at a consistent time, removing electronic devices from the bedroom, and avoiding caffeine, alcohol, and heavy meals near bedtime. While these efforts can improve sleep, they are not a treatment for disordered sleep. “A lot of people confuse sleep hygiene with behavioral sleep therapies. This is a huge misconception,” Grandner said. Hygiene, by nature, is preventive. “Washing your hands can prevent you from getting sick, but it won’t cure an infection. And sleep hygiene can remove some barriers to good sleep, but it’s mostly useless for fixing insomnia,” he added.

Another fallacy is that insomnia is a symptom of mental health disorders. While the two often coexist, they are best thought of as comorbid conditions, said Michael Perlis, PhD, director of the Behavioral Sleep Medicine Program at the University of Pennsylvania Perelman School of Medicine. “When sleep disorders are viewed as a symptom of an illness, people believe there’s no need for targeted action. They believe that by treating the PTSD, anxiety, or depression, insomnia will abate. The past 10 years of research shows us that doesn’t happen,” he said.

While treating mental health conditions does not guarantee improvement of comorbid insomnia, the reverse is more likely: Treating insomnia can make mental health disorders more manageable. A meta-analysis of randomized controlled trials showed that poor sleep is causally related to mental health difficulties and that greater improvements in sleep quality lead to greater improvements in mental health (Scott, A. J., et al., 


Sleep Medicine Reviews

, Vol. 60, 2021
). For that reason, some sleep experts argue that insomnia should be treated even before other mental health problems, if the patient is not in crisis. “When insomnia is left alive, it complicates the treatment of everything else,” said Donn Posner, PhD, adjunct clinical associate professor at Stanford University School of Medicine and founder of Sleepwell Consultants, which offers sleep interventions for patients and workshops for providers. “Every time you see chronic insomnia, you need to treat it.”

CBT-I: Front-line insomnia treatment

Almost anything can trigger a night of tossing and turning, from stress to pain to stormy weather. “There are a million causes of short-term insomnia. But there is one main culprit behind chronic insomnia—conditioned arousal,” said Grandner. “When sleep becomes problematic, the bed becomes the war zone. And then the expectation that sleep will be stressful creates the very activation that makes sleep difficult.”

The best treatment to address that conditioned arousal is cognitive behavioral therapy for insomnia (CBT-I), a targeted intervention that typically lasts four to eight sessions. In fact, CBT-I is one of psychology’s best success stories. The treatment is so effective that it is recommended as a front-line treatment for insomnia by a variety of professional groups, including the Department of Veterans Affairs/Department of Defense Health Affairs, the American College of Physicians, and the AASM.

Even in cases of short-term insomnia, CBT-I is about as effective as sleeping pills. In a meta-analysis that included 21 studies, researchers concluded that behavioral therapy produces similar outcomes as pharmacotherapy for the acute treatment of primary insomnia (Smith, M. T., et al., 


The American Journal of Psychiatry

, Vol. 159, No. 1, 2002
). But for chronic insomnia, CBT-I is at a distinct advantage. A meta-analysis concluded that the intervention is an effective treatment for adults with chronic insomnia, with clinically meaningful effect sizes (Trauer, J. M., et al., 


Annals of Internal Medicine

, Vol. 163, No. 3, 2015
). “In the long term, there’s an advantage for CBT-I because it actually addresses the underlying behavioral and thought patterns that perpetuate the insomnia,” Mundt said. “And it has a high rate of success.”

CBT-I is also a successful option for patients with insomnia and depression. In a study of internet-delivered CBT-I, Kerstin Blom, PhD, at the Karolinska Institutet in Sweden, and colleagues found that in patients with both diagnoses, CBT-I was more effective than CBT for depression when treating insomnia. More surprising, the two were equally effective for reducing depression severity. At a 3-year follow-up, both the CBT-I and CBT for depression groups continued to experience similar reductions in depression severity, but the insomnia treatment continued to have superior effects on sleep (


Sleep

, Vol. 38, No. 2, 2015
; 


Sleep

, Vol. 40, No. 8, 2017
).

Other research also supports the idea that CBT-I can improve depression. A systematic review of 18 studies concluded that CBT-I is a promising treatment for depression in people who also have insomnia and produces effects of roughly the same magnitude as antidepressant medications. In-person therapy had the most evidence supporting its efficacy, while evidence for telehealth CBT-I was mixed. However, the authors concluded there is promise for a stepped-care approach in which telehealth progresses to in-person therapy for patients as needed (Cunningham, J. E. A., & Shapiro, C. M., 


Journal of Psychosomatic Research

, Vol. 106, 2018
).

There’s further evidence that treating insomnia might even prevent depression from developing in the first place. In a study by researchers at Henry Ford Health and the University of Oxford, participants with insomnia were randomized to receive either digital CBT-I or sleep education. In those with minimal to no depression at baseline, the incidence of moderate-to-severe depression one year later was reduced by half in the CBT-I group compared with the sleep education control condition (Cheng, P., et al., 


Sleep

, Vol. 42, No. 10, 2019
).

Research also supports the use of CBT-I in patients with insomnia and other mental health conditions. One randomized trial by Lisa Talbot, PhD, at the San Francisco VA Medical Center, and colleagues found that an eight-session CBT-I intervention improved sleep and overall psychosocial functioning in people with PTSD compared with participants in a waiting list control group. There was also some evidence that CBT-I may reduce the frequency of nightmares in people with PTSD (


Sleep

, Vol. 37, No. 2, 2014
).

Meanwhile, Grandner and colleagues explored the connection between COVID-19 pandemic-related stress and anxiety, suicidal ideation, and sleep. They found that COVID anxiety was correlated with suicidal ideation—but that association was fully accounted for by insomnia severity. Treating the insomnia, in other words, may help to reduce suicide risk in people with high stress or anxiety (


Psychiatry Research

, Vol. 290, No. 113124, 2020
).

Recognizing other sleep disorders

Insomnia, while common, is hardly the only sleep disorder that psychologists are likely to encounter in their practice. About 25 million adults in the United States—more than a quarter of adults ages 30 to 70—have obstructive sleep apnea, according to the AASM. This disorder occurs when muscles in the throat relax, blocking the airway. People with obstructive sleep apnea repeatedly stop breathing for short periods during sleep, disrupting sleep continuity and causing daytime fatigue. Untreated, sleep apnea can increase the risk of serious conditions, including diabetes, heart disease, and mood and psychiatric disorders.

The front-line treatment for obstructive sleep apnea is positive airway pressure (PAP), a face mask device that pushes air into the airway to keep it open during sleep. While PAP treatment is effective, adherence can be an issue. Psychologists can help patients learn to tolerate the device. “People who specialize in behavioral sleep medicine can help with adherence and anxiety for PAP. When patients are struggling to wear the mask or have anxiety or claustrophobia, we can use exposure treatments to help them get comfortable using the device,” Mundt said.

Nightmares are another common complaint, especially in people who have been exposed to trauma. Counter to popular belief, nightmares are treatable. Imagery rehearsal therapy (IRT) is one of the most used and well-supported interventions for nightmares in people with PTSD, and several protocols are available. A meta-analysis of these cognitive behavioral interventions found IRT had large effects on the frequency of nightmares, sleep quality, and PTSD symptoms. Further, the combination of IRT and CBT-I resulted in even greater improvements in sleep quality (Casement, M. D., & Swanson, L. M., 


Clinical Psychology Review

, Vol. 32, No. 6, 2012
). “It’s helpful to ask patients about nightmares because they are so common, especially with trauma,” Mundt said. “And patients aren’t necessarily going to bring them up, because they don’t even know that treatments are out there.”

Another challenging condition is hypersomnia, which causes excessive sleepiness even after a full night’s sleep. Examples of central disorders with hypersomnolence include conditions such as narcolepsy and Kleine-Levin syndrome, a rare disorder that causes excessive sleep, hunger, and behavioral changes. Hypersomnia can also be idiopathic, meaning it has no known cause. Secondary hypersomnia can be associated with certain medical disorders (such as epilepsy, hypothyroidism, or nervous system disorders), mood disorders such as depression and bipolar disorder, or other causes, such as side effects from medications. “These disorders are less common, but they frequently go undiagnosed or misdiagnosed for years,” Mundt said.

She and her colleagues are developing a cognitive behavioral therapy for hypersomnia (CBT-H). An initial pilot study suggested the treatment may reduce depressive symptoms and improve self-efficacy in people with hypersomnia and coexisting depression (Ong, J. C., et al., 


Journal of Clinical Sleep Medicine, Vol. 16, No. 12, 2020

). “The main treatment for hypersomnia is medication to help with alertness. This is an adjunctive treatment to address the psychosocial impacts of hypersomnia,” Mundt said.

“There’s often comorbid depression and anxiety and issues with stigma and navigating work and relationships. CBT-H is designed to help people deal with those challenges.”

Sleep training for psychologists

Given the frequency of sleep disruption in the general population—and among people with mental health disorders in particular—it is important for clinicians to recognize the signs. Clinical psychologists should make a point to inquire about their patients’ sleep habits, Grandner said. “Sleep problems are part of practically every diagnosis in the DSM,” he said.

Yet it is also important to recognize that treating insomnia and other sleep disorders requires specialized training. For psychologists who are trained in CBT, learning CBT-I is not especially difficult, Grandner said. “The treatment is highly manualized, and you don’t need to be board certified in behavioral sleep medicine to become competent in CBT-I.” However, being competent in CBT-I does require training in principles of sleep medicine that go beyond the traditional behavioral and cognitive tools, and various training options are available online and in person at institutions such as the University of Pennsylvania, University of Oxford, University of Arizona, and others. (See 

Screening tools and other resources
.)

Perlis and Posner, who lead training courses in CBT-I and are coauthors of a treatment manual on the intervention, argue that many more psychologists would benefit from these trainings—and so would their patients. Currently, most of the participants in Perlis’s training courses come from allied fields such as social work and occupational therapy, he said. “We clinical psychologists designed CBT-I. We produced the evidence base. Why are we not the ones delivering it?” he asked. “We need more people in clinical psychology to come aboard and start seeking training.”

Addressing sleep hygiene is something all clinicians can do with their patients. But sleep hygiene alone is not sufficient for treating clinically significant insomnia, Rubman said. If sleep problems persist for more than a few weeks, it is important to refer patients to a physician or psychologist who is certified in behavioral sleep medicine or has training in CBT-I. Too often, patients receive sleep education but do not improve, and then they mistakenly conclude that behavioral interventions didn’t work for them and may turn to sleeping pills instead. That is a missed opportunity, since their insomnia is likely to improve or resolve if they are treated with CBT-I. “Clinicians need a good understanding of variations in normal sleep and the limits of sleep hygiene, and they need to recognize when to refer someone to a specialist,” she said. “The goal is to intervene to prevent an acute problem from becoming a chronic problem.”

Screening tools and other resources

Epworth sleepiness scale

(Johns, M. W., 
Sleep, Vol. 14, No. 6, 1991)

Insomnia Severity Index

(Morin, C. M., et al., 
Sleep, Vol. 34, No. 5, 2011)

Sleep Disorders Symptom Checklist-25

(Klingman, K. J., et al., 
Sleep Medicine Research, Vol. 8, No. 1, 2017)

STOP-Bang questionnaire for sleep apnea

(Tan, A., et al., 
Sleep Medicine, Vol. 27–28, 2016)

Society of Behavioral Sleep Medicine
 (resources, education, and provider directory)

International Directory of CBT-I Providers

Web-based course in CBT-I

Further reading

Cognitive behavioral treatment of insomnia

Perlis, M. L., et al., Springer, 2005

Principles and practice of sleep medicine, 7th edition

Kryger, M. H., et al., Elsevier, 2022

Behavioral treatments for sleep disorders

Perlis, M., et al. (Eds.), Elsevier, 2011

Treatment plans and interventions for insomnia: A case formulation approach

Manber, R., & Carney, C. E., Guilford Press, 2015

Emily Grace and the what-ifs: A story for children about nighttime fears

Gehring, L. B., Magination Press, 2016

1. What screening tools can be used to affirm your initial diagnosis that a patient may meet

the diagnostic criteria for a sleep disorder?

Having a sleep disorder can be crippling to a person’s life and relationships. Research has

expressed that it can exacerbated, or quality of life can be decreased, and fatigue and sleepiness

can have very bad consequences. The screening tool that I would use for distinguishing insomnia

would be the Athens Insomnia Screening (AIS). The consistency and reliability of the AIS

determines for me to be invaluable tool in the clinical practice. this tool helps determine the

factors that affect the inability to sleep. The AIS has 8 items that are used for screening insomnia.

The first 5 items pertain to sleep induction, awakening during the night, final awakening, total

sleep duration, and sleep quality. The last three refer to wellbeing, functioning capacity, and

sleepiness during the day

2. Describe the pharmacological actions of non-z sleep medications?

Zolpidem, Zaleplon, and Eszopiclone are examples of non-z sleep medications. Nonbenzodiazepines work by enhancing a very important neurotransmitter called GABA at the

GABA A receptor. The nonbenzodiazepine hypnotics facilitate GABA A transmission by

preferential binding to the 1a receptor subunits.

3. What problems can occur when benzodiazepines are used to help with sleep?

Benzodiazepines can be used for a short term for insomnia, however there are side effects from

the use of benzodiazepines such as addiction. There are additional medications to explore for

long term use for insomnia they are associated with residual daytime sedation, rebound

insomnia, and anterograde amnesia that can be controlled by their pharmacokinetic properties.

There is a low abuse potential for these classes of drugs when taken for an extended period,

withdrawal and tolerance to the hypnotic effects can become prevalent, and long-term use has

not been studied systematically.

See Attached 

 Due 10/13/23 @ 1600 EST

Respond by sharing ideas for how shortcomings discovered in their evaluations and/or their examples of incivility could have been managed more effectively. 

using APA, at least 2 scholarly references 

 

WORKPLACE ENVIRONMENT ASSESSMENT

I recently conducted a Work Environment Assessment to evaluate workplace civility in the acute psychiatric inpatient unit. The results of the assessment painted a mixed picture. On the positive side, most staff members consistently exhibited professionalism and respect in their interactions with colleagues and patients. Team collaboration during shift handoffs and interdisciplinary meetings was generally effective and respectful.

.However, the assessment also revealed challenges. There were instances of incivility during high-stress situations, such as patient crises or when dealing with challenging patients. Communication breakdowns occurred when staff members were overwhelmed, leading to frustration and occasional conflicts. Some employees expressed concerns about a lack of adequate resources, contributing to heightened tensions ((Abt et al.,2021)

.Overall, the workplace in the psychiatric inpatient unit could be characterized as moderately civil. While there were numerous examples of professionalism and respect, the high-stress nature of the environment occasionally led to lapses in civility. In my personal experience, I encountered incivility during a team debriefing following a challenging patient case. The charge nurse became frustrated with a staff member she believed had not followed protocol during the crisis, leading to a heated argument in front of the team.

This situation needed urgent action to stop any further deterioration. The parties could speak freely and with less hostility because of this one-to-one discussion. The clinical supervisor subsequently mediated the process, delving into the underlying issues to devise an alternative means of communication between the two parties. The latter included conflict resolution/communication training that was introduced in advance. An acute psychiatric inpatient unit is a high-stress healthcare setting where it is essential to deal with incivility simultaneously to maintain a therapeutic and civil working environment (Mabona et al.,2022).

References

Abt, M., Lequin, P., Bobo, M., Vispo Cid Perrottet, T., Pasquier, J., & Ortoleva Bucher, C. (2021). The scope of nursing practice in a psychiatric unit: A time and motion study. Journal of Psychiatric and Mental Health Nursing, 29(2), 297–306. https://doi.org/10.1111/jpm.12790Links to an external site.

Kwame, A., & Petrucka, P. M. (2021). A literature-based study of patient-centered care and communication in nurse-patient interactions: Barriers, facilitators, and the way forward. BMC Nursing, 20(1). https://doi.org/10.1186/s12912-021-00684-2Links to an external site.

Mabona, J. F., Van Rooyen, D., & Ten Ham-Baloyi, W. (2022). Best practice recommendations for healthy work environments for nurses: An integrative literature review. Health SA Gesondheid, 27. https://doi.org/10.4102/hsag.v27i0.1788

• Reflect on your philosophy of nursing practice that you have been developing.
• Review the middle range nursing theories that you have applied to your philosophy of nursing practice and make any necessary refinements in your thinking and explanations.
• Consider how the interdisciplinary theory you researched  can further inform your philosophy of nursing practice. 

Complete your written philosophy of nursing practice in a Essa y of 3–5 pages, plus cover page, introduction, summary and references page.

2

PICOT Question for Preventing Childhood Obesity

Tahimi Salfran Mesa

Florida National University

Professor: Yesenia Osle

September 15, 2023

PICOT Question for Preventing Childhood Obesity

Obesity is a pressing public health issue with serious long-term consequences. Obesity is a chronic medical condition characterized by excessive body fat. A body mass index (BMI) of 25 or above is considered overweight, and a BMI of 30 or higher is considered obese (WHO, 2021). Obesity has witnessed a global upswing, with a particularly alarming impact on children, sparking significant public health apprehension. Childhood obesity has become a pressing global concern, transcending the confines of adulthood. The alarming trend exposes children to immediate obesity-related health risks and casts a shadow over their future. Children are categorized as overweight or obese based on their BMI exceeding age and gender-specific thresholds. Precise height and weight assessments form a crucial aspect of routine physical examinations. Childhood obesity sets the stage for a lifelong battle, predisposing youngsters to adult obesity and a spectrum of non-communicable diseases like diabetes mellitus, hypertension, and osteoarthritis in adulthood.

Childhood obesity is driven by complex interplay of genetic, environmental, and behavioral factors. Genetic predisposition increases child's susceptibility to obesity. Environmental factors entail easy access to high-calorie, low-nutrient foods, and sedentary lifestyles influenced by modern technology and urbanization (Lister et al., 2023). Lower-income families may have limited access to fresh, nutritious foods and safe places for physical activity. Advertising of unhealthy foods and beverages targeted at children further exacerbates the problem. Behavioral factors are the psychological factors driving stress and emotional eating that hinder healthy habits. Addressing this burgeoning crisis demands urgent, comprehensive action to safeguard the well-being of our youngest generation and mitigate the far-reaching health consequences they face in adulthood. This paper explores the problem of obesity and identifies effective prevention strategies are essential to mitigate the growing concern using the PICOT framework.

Problem Statement

Childhood obesity rates have been steadily increasing worldwide. The global prevalence of overweight and obese children has risen dramatically in recent years. The World Health Organization (2021) reports that in 2020, 39 million children under five were overweight or obese. Over the past four decades, the global count of school-age children and adolescents grappling with obesity has skyrocketed by over tenfold, surging from 11 million to a staggering 124 million by 2016. Additional 216 million fell into the category of being overweight but not yet classified as obese in 2016. The numbers are projected to substantially increase by 2030.

The primary driver of obesity and overweight issues worldwide stems from a crucial energy imbalance: consuming calories exceeding those expended. The global challenge is exacerbated by an alarming surge in the consumption of energy-dense foods rich in fats and sugars and rise in physical inactivity (Fox et al., 2019). The latter can be attributed to the increasingly sedentary nature of many job roles, shifts in transportation methods, and the expanding urban landscape. These dietary habits and activity levels shifts often result from broader environmental and societal changes linked to development.

Childhood obesity elevates the risk of numerous health issues, encompassing asthma, sleep apnea, bone and joint problems, type 2 diabetes, and precursors to heart disease like high blood pressure. It also exerts substantial impact on healthcare costs. In adulthood, individuals grappling with obesity face increased susceptibility to stroke, various cancers, heart disease, type 2 diabetes, premature mortality, and mental health conditions such as clinical depression and anxiety. Therefore, childhood obesity carried over to adulthood will expose them to these problems. The problem affects both developed and developing nations. However, gender disparities are relatively minimal. Addressing the escalating obesity epidemic necessitates a comprehensive approach considering genetic predispositions and environments that encourage unhealthy behaviors. However, identifying the most effective strategies and interventions for specific populations is crucial.

PICOT Question

In school-aged children (P), does a comprehensive school-based nutrition and physical activity program (I) compared pharmacological interventions (C) reduce prevalence of obesity over 12-month period?

Explanation of PICOT Components

Population of Interest (P)

The population of interest for this PICOT question is school-aged children, typically ranging from 5 to 18 years old. The age group is particularly susceptible to obesity due to dietary habits, physical activity levels, and environmental influences. Childhood often emerges as a pivotal phase in development. It is increasingly acknowledged as a critical period influencing an individual's susceptibility to obesity in later life (Smith et al., 2020). During this window, taste preferences, dietary patterns, and lifestyle behaviors take shape and have a lasting impact. Interventions implemented during these early years possess the potential to redirect this trajectory, reshaping a child's preferences and habits before they solidify, offering a vital opportunity to mitigate the risk of obesity in the future.

Intervention of Interest (I)

The intervention of interest is a comprehensive school-based nutrition, behavioral therapy, and physical activity program. School-based nutrition interventions are strategies enacted within school environments to cultivate positive nutritional attitudes, knowledge, and behaviors in school-aged children and adolescents (O’Brien et al., 2021). These initiatives encompass various facets, including food policies, environmental enhancements, and nutrition education. Their recipients may range from school administrators, food service personnel, and teachers to parents and students. Conventional classroom educators or specialized program instructors can carry out implementation.

Physical activities are bodily engagements that require energy expenditure. They encompass exercises, sports, recreational pursuits, and daily tasks like walking or climbing stairs. Encouraging regular exercise helps children achieve and maintain a healthy weight while promoting overall well-being. Activities should be age-appropriate, enjoyable, and integrated into daily life. School-aged children and adolescents should engage in minimum of 60 minutes of daily physical activity, with at least 30 minutes devoted to structured activities like sports and supervised exercises, aligning with recommendations by the American Academy of Pediatrics (van Sluijs et al., 2021). Behavioral therapy focuses on modifying unhealthy behaviors and promoting positive lifestyle changes. It encourages self-monitoring, where children track their eating habits, physical activity, and food-related emotions. Second, the education encourages setting specific, achievable goals for healthier eating and increased physical activity tailored to their age and abilities.

Comparison of Interest (C)

The comparison of interest in this PICOT question is pharmacological intervention. Pharmacological intervention encompasses using pharmaceutical agents or drugs to manage obesity in children. These interventions include prescription medications like orlistat for reducing fat absorption in the digestive tract or metformin to regulate blood sugar levels and treat obesity-related insulin resistance (Florencia et al., 2022). Other weight management medications may also be considered, although their use in pediatric populations is generally more limited and carefully monitored due to potential side effects. Comparing the effectiveness of these pharmacological interventions with comprehensive school-based nutrition and physical activity programs is essential to determine the most appropriate and beneficial approach to address childhood obesity.

Outcome of Interest (O)

The primary outcome of interest is the body mass index (BMI) percentile reduction. BMI percentile is a commonly used metric to assess and monitor children's weight status. Decrease in BMI percentile indicates positive change in weight status and reflect progress in preventing childhood obesity.

Timeframe (T)

The proposed timeframe for implementing and evaluating the comprehensive school-based program's impact on BMI percentile is 12 months. The duration ensures comprehensive assessment of intervention's effectiveness over reasonable period.

Conclusion

Childhood obesity is a growing public health concern with far-reaching consequences. It stems from energy imbalance and has intensified due to increased consumption of energy-dense foods and reduced physical activity, driven by societal changes. Childhood obesity exposes children to immediate health risks and sets foundation fo lifelong battle with obesity-related diseases in adulthood. Interventions for combating childhood obesity should consider the complex interplay of genetic, environmental, and behavioral factors. Addressing childhood obesity requires comprehensive strategies illustrated through the PICOT framework. The outlined PICOT question focuses on school-aged children and impact of comprehensive school-based nutrition and physical activity program on BMI percentile reduction over 12 months. The question is designed to guide research and evaluation efforts in determining effectiveness of such interventions in preventing childhood obesity. Comparing the approach with pharmacological interventions is critical in determining appropriate effective path forward.

References

CDC. (2022, August 29).
Preventing Childhood Obesity: 4 Things Families Can Do. Centers for Disease Control and Prevention. https://www.cdc.gov/nccdphp/dnpao/features/childhood-obesity/index.html

Florencia, M., Gonzalez, C., Hirschler, V., & Guillermo Di Girolamo. (2022). Pharmacotherapeutic options in pediatric obesity: an urgent call for further research.
Expert Opinion on Pharmacotherapy,
23(8), 869–872. https://doi.org/10.1080/14656566.2022.2050212

Fox, A., Feng, W., & Asal, V. (2019). What is driving global obesity trends? Globalization or “modernization”?
Globalization and Health,
15(1). https://doi.org/10.1186/s12992-019-0457-y

Lister, N. B., Baur, L. A., Felix, J. F., Hill, A. J., Marcus, C., Reinehr, T., Summerbell, C., & Wabitsch, M. (2023). Child and adolescent obesity.
Nature Reviews Disease Primers,
9(1), 1–19. https://doi.org/10.1038/s41572-023-00435-4

O’Brien, K. M., Barnes, C., Yoong, S., Campbell, E., Wyse, R., Delaney, T., Brown, A., Stacey, F., Davies, L., Lorien, S., & Hodder, R. K. (2021). School-Based Nutrition Interventions in Children Aged 6 to 18 Years: An Umbrella Review of Systematic Reviews.
Nutrients,
13(11), 4113. https://doi.org/10.3390/nu13114113

Smith, J. D., Fu, E., & Kobayashi, M. A. (2020). Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities.
Annual Review of Clinical Psychology,
16(1), 351–378. https://doi.org/10.1146/annurev-clinpsy-100219-060201

van Sluijs, E. M. F., Ekelund, U., Crochemore-Silva, I., Guthold, R., Ha, A., Lubans, D., Oyeyemi, A. L., Ding, D., & Katzmarzyk, P. T. (2021). Physical activity behaviours in adolescence: current evidence and opportunities for intervention.
The Lancet,
398(10298). https://doi.org/10.1016/s0140-6736(21)01259-9

World Health Organization. (2021, June 9).
Obesity and Overweight. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight